Kenneth J. Caldwell

542 total citations
21 papers, 335 citations indexed

About

Kenneth J. Caldwell is a scholar working on Hematology, Molecular Biology and Neurology. According to data from OpenAlex, Kenneth J. Caldwell has authored 21 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Kenneth J. Caldwell's work include Acute Myeloid Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Kenneth J. Caldwell is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Kenneth J. Caldwell collaborates with scholars based in United States, Iran and United Kingdom. Kenneth J. Caldwell's co-authors include Stephen Gottschalk, Aimee C. Talleur, Haley Houke, Timothy I. Shaw, Zhongzhen Yi, Xiaoyan Zhu, Giedre Krenciute, Jennifer L. Stripay, Peter Vogel and Suzanne J. Baker and has published in prestigious journals such as Blood, PLoS ONE and Cancer.

In The Last Decade

Kenneth J. Caldwell

21 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenneth J. Caldwell United States 9 185 103 83 60 46 21 335
Maria Ormhøj Denmark 7 231 1.2× 124 1.2× 97 1.2× 74 1.2× 18 0.4× 14 382
Matthias Mulazzani Germany 9 178 1.0× 56 0.5× 184 2.2× 55 0.9× 64 1.4× 11 393
Khalifa El Malki Germany 10 215 1.2× 138 1.3× 182 2.2× 48 0.8× 44 1.0× 19 520
Г. В. Селедцова Russia 12 137 0.7× 92 0.9× 252 3.0× 23 0.4× 37 0.8× 51 433
Aaron Victor United States 7 256 1.4× 86 0.8× 293 3.5× 33 0.6× 28 0.6× 12 442
Robin Sanderson United Kingdom 9 229 1.2× 52 0.5× 23 0.3× 39 0.7× 39 0.8× 28 315
Jessie M. Wu United Kingdom 8 238 1.3× 122 1.2× 128 1.5× 52 0.9× 14 0.3× 13 441
Shilpa Alekar United States 5 475 2.6× 94 0.9× 152 1.8× 44 0.7× 63 1.4× 5 655
Stephanie Rawlings-Rhea United States 8 436 2.4× 135 1.3× 89 1.1× 153 2.5× 21 0.5× 15 486
David Stroncek United States 9 233 1.3× 151 1.5× 109 1.3× 54 0.9× 19 0.4× 18 455

Countries citing papers authored by Kenneth J. Caldwell

Since Specialization
Citations

This map shows the geographic impact of Kenneth J. Caldwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth J. Caldwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth J. Caldwell more than expected).

Fields of papers citing papers by Kenneth J. Caldwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth J. Caldwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth J. Caldwell. The network helps show where Kenneth J. Caldwell may publish in the future.

Co-authorship network of co-authors of Kenneth J. Caldwell

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth J. Caldwell. A scholar is included among the top collaborators of Kenneth J. Caldwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth J. Caldwell. Kenneth J. Caldwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Lisa D., Marlen Metzner, François G. Kavelaars, et al.. (2024). Mutational Landscape and Depth of Response in Patients with Acute Myeloid Leukemia (AML) Treated with Magrolimab in Combination with Venetoclax and Azacitidine Compared to Placebo. Blood. 144(Supplement 1). 2914–2914. 1 indexed citations
2.
3.
4.
Caldwell, Kenneth J., et al.. (2022). Relapsed acute myeloid leukemia in children and adolescents: current treatment options and future strategies. Leukemia. 36(8). 1951–1960. 14 indexed citations
5.
Caldwell, Kenneth J., et al.. (2022). Bevacizumab, With Sorafenib and Cyclophosphamide Provides Clinical Benefit for Recurrent or Refractory Osseous Sarcomas in Children and Young Adults. Frontiers in Oncology. 12. 864790–864790. 7 indexed citations
6.
Caldwell, Kenneth J., et al.. (2021). Clinical and biological aspects of myeloid leukemia in Down syndrome. Leukemia. 35(12). 3352–3360. 19 indexed citations
7.
Caldwell, Kenneth J., Stephen Gottschalk, & Aimee C. Talleur. (2021). Allogeneic CAR Cell Therapy—More Than a Pipe Dream. Frontiers in Immunology. 11. 618427–618427. 99 indexed citations
8.
Khan, Faraz A., et al.. (2021). Prehospital personnel discretion pediatric trauma team activations: Too much of a good thing?. Journal of Pediatric Surgery. 56(11). 2052–2057. 2 indexed citations
9.
Hu, Yixin, Kenneth J. Caldwell, Mihaela Onciu, et al.. (2021). CPX-351 induces remission in newly diagnosed pediatric secondary myeloid malignancies. Blood Advances. 6(2). 521–527. 6 indexed citations
10.
Shulkin, Barry L., et al.. (2020). Induction Chemotherapy With an Anti-GD2 Monoclonal Antibody (Dinutuximab) and Cytokines in Children With Newly Diagnosed High-risk Neuroblastoma: A Case Series. Journal of Pediatric Hematology/Oncology. 43(5). e692–e696. 7 indexed citations
11.
Federico, Sara M., Kenneth J. Caldwell, M. Beth McCarville, et al.. (2020). Phase I expansion cohort to evaluate the combination of bevacizumab, sorafenib and low-dose cyclophosphamide in children and young adults with refractory or recurrent solid tumours. European Journal of Cancer. 132. 35–42. 13 indexed citations
12.
Caldwell, Kenneth J., et al.. (2020). A newborn with a large NTRK fusion positive infantile fibrosarcoma successfully treated with larotrectinib. Pediatric Blood & Cancer. 67(9). e28330–e28330. 14 indexed citations
13.
Haydar, Dalia, Haley Houke, Jason Chiang, et al.. (2020). Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery. Neuro-Oncology. 23(6). 999–1011. 89 indexed citations
14.
Caldwell, Kenneth J., et al.. (2018). Child With Autism and a Limp. Annals of Emergency Medicine. 72(4). 493–495. 3 indexed citations
15.
Mocco, J, Aqeela Afzal, Saeed Ansari, et al.. (2014). SDF1-A Facilitates Lin−/Sca1+ Cell Homing following Murine Experimental Cerebral Ischemia. PLoS ONE. 9(1). e85615–e85615. 11 indexed citations
16.
Ansari, Saeed, Hassan Azari, Kenneth J. Caldwell, et al.. (2013). Endothelin-1 Induced Middle Cerebral Artery Occlusion Model for Ischemic Stroke with Laser Doppler Flowmetry Guidance in Rat. Journal of Visualized Experiments. 19 indexed citations
17.
Regenhardt, Robert W., Saeed Ansari, Hassan Azari, Kenneth J. Caldwell, & Adam P. Mecca. (2013). Utilizing a Cranial Window to Visualize the Middle Cerebral Artery During Endothelin-1 Induced Middle Cerebral Artery Occlusion. Journal of Visualized Experiments. e50015–e50015. 3 indexed citations
18.
Ansari, Saeed, Hassan Azari, Kenneth J. Caldwell, et al.. (2013). Endothelin-1 Induced Middle Cerebral Artery Occlusion Model for Ischemic Stroke with Laser Doppler Flowmetry Guidance in Rat. Journal of Visualized Experiments. 5 indexed citations
19.
Jiménez, Jessica A., Kenneth J. Caldwell, Jeff A. Anderson, et al.. (2008). Construction of a physical model of a farnesyltransferase‐inhibitor complex: Insight into a novel therapy for Hutchinson‐Guilford Progeria. The FASEB Journal. 22(S2). 342–342. 2 indexed citations
20.
Caldwell, Kenneth J.. (1980). Mitogenic Response to Toxocara Antigen and Chemotactic Defect in Visceral Larva Migrans. Archives of Pediatrics and Adolescent Medicine. 134(9). 845–845. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Ormhøj Breakdown of academic impact, for papers by Matthias Mulazzani Breakdown of academic impact, for papers by Khalifa El Malki Breakdown of academic impact, for papers by Г. В. Селедцова Breakdown of academic impact, for papers by Aaron Victor Breakdown of academic impact, for papers by Robin Sanderson Breakdown of academic impact, for papers by Jessie M. Wu Breakdown of academic impact, for papers by Shilpa Alekar Breakdown of academic impact, for papers by Stephanie Rawlings-Rhea Breakdown of academic impact, for papers by David Stroncek
Rankless by CCL
2026